Skip to main content
Advertisement
Live broadcast

Russia has developed an alcohol-based drug for the treatment of arrhythmias

0
Photo: IZVESTIA/Sergey Lantyukhov
Озвучить текст
Select important
On
Off

Novosibirsk has developed a drug based on ethyl and isobutyl alcohols for the treatment of cardiac arrhythmias. This was announced on October 29 at the NMC named after Academician E.N. Meshalkin in Novosibirsk.

"A medicinal product for the treatment of cardiac arrhythmias. Preclinical trials have been completed, and now we are waiting for the first phase of clinical trials of this drug," said Evgeny Tarasyuk, director of the center, TASS.

The drug is a combination of ethyl and isobutyl alcohols with the addition of a disulfiram stabilizer. It is assumed that the drug will be injected using a balloon catheter directly into the coronary sinus, a large vein of the heart.

According to Romanov, the combination of alcohols should have a local effect on the areas of the heart tissue that cause arrhythmia.

The start of studies with patients is tentatively scheduled for mid-November. If all the stages are successfully completed, the drug may appear on the market in 2029-2030. Its estimated cost will be about 15 thousand rubles.

On October 1, the Scandinavian Health Center announced the start of pilot testing of the Evipatch portable cardio recorder from the Moscow company Evimed. The device works wirelessly and does not interfere with daily activities. The recordings are analyzed by algorithms that help identify cardiac arrhythmias, including episodes of atrial fibrillation.

Переведено сервисом «Яндекс Переводчик»

Live broadcast